Trevi Therapeutics, Inc. Profile Avatar - Palmy Investing

Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation…

Biotechnology
US, New Haven [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Trevi Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Trevi Therapeutics, Inc. has no acquisition track records yet.

End of TRVI's Analysis
CIK: 1563880 CUSIP: 89532M101 ISIN: US89532M1018 LEI: - UEI: -
Secondary Listings
TRVI has no secondary listings inside our databases.